Obesity-focused biotech BioAge Labs said on Wednesday it was seeking a valuation of as much as $587 million in its initial ...

BioAge Labs Inc., a clinical-stage biotechnology company developing therapies for obesity and metabolic disease, is seeking ...

Obesity drug developer BioAge Labs (BIOA) files for U.S. IPO to offer 7.5M shares at $17-$19 implying valution of up to $602M ...

Healthcare firms have done comparatively well in an otherwise subdued U.S. IPO market in 2024, which analysts touted as a comeback year for public offerings. The Richmond, California-based company ...

BioAge Labs, a clinical-stage biotech firm focused on obesity and metabolic disease therapies, aims to raise up to $157.5 million through its initial public offering and private placement, Bloomberg ...

Reuters.com is your online source for the latest news stories and current events, ensuring our readers up to date with any ...

queue amid a flurry of IPO activity in the sector, with three biotechs listing on the Nasdaq last week – Bicara Therapeutics, ...

Our round-up of financings in the biotech sector this week is led by BioAge Lab's filing of an initial public offering (IPO), with a placeholder target of $100 million, plus sizeable private ...

Six IPOs debuted this past week, including three deals of more than $100 million. Seven IPOs submitted initial filings.

Sahaj Solar IPO subscription status was 42.23 times, on day 1, and the issue was booked 97.98 times, on day 2. The Sahaj Solar IPO, worth ₹52.56 crore, is purely an offer-for-sale of up to ...

TBO Tek IPO allotment date: The TBO Tek IPO share allotment has been finalised. The allotment process began on Monday, May 13. Investors who applied for the TBO Tek IPO can check the TBO Tek IPO ...